All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @griselenciso on TikTok · 274s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @griselenciso's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'll do that in a minute, anyway.
  2. 0:05I'm going to leave my friend,
  3. 0:07if she's moved, and is going to be home,
  4. 0:12I'm going to leave here today because we just
  5. 0:16have to go to school,
  6. 0:18and I'm going to take her home,
  7. 0:21and I'll go to the house and go there again.
  8. 0:27The name is L'Ohères Dratard, too.
  9. 0:31I'm here with the professor at the University of Twíste,
  10. 0:36and I'm here at the University of Tsar.
  11. 0:40I'm here at the University of Zouil,
  12. 0:44and here is the principal here,
  13. 0:49and I'm here for the student room,
  14. 0:53in meirio.
  15. 0:55Unle meirle, puntosink, aquista, complete it.
  16. 1:02Elotro, puntosinko, lo vuia, complete it.
  17. 1:12Con aqua acida, o acerit, water.
  18. 1:17Mi heringilla es de cinquentón y dades, y esta la vuia yener,
  19. 1:23toda completamente.
  20. 1:25Para ao di tenemos que aderiz,
  21. 1:28las dos aos muy lentamente y primeros y aderiz, el patuar.
  22. 1:36Por quesia aderimos ela vuia acida, es te vu te cito,
  23. 1:41em pisa a inflamarse y entonces, se ase hil.
  24. 1:47Evi esto muchas personas, de pandiendo de donde lo conprin,
  25. 1:52o que esta consentra dosta, es te le hos de quedar,
  26. 1:56ela gua clara, les que da de una manera como,
  27. 2:03revulcada ela gua, semira turvia, pero lo lo lo,
  28. 2:10le que da suficiente para poderce aplicar.
  29. 2:14In esta caso, lo vamos a ser como y dado, y bamos amister,
  30. 2:19ela gua, muy lentamente.
  31. 2:25Me o verde comentarles que tanto mi viel, como ela gua,
  32. 2:30es tanto a tempera tura ambiente, y esto perminte que se
  33. 2:34disu
  34. 2:58esta por emamento se ve un poco turvia,
  35. 3:03pero esta lo suficiente le que da para poderce aplicar.
  36. 3:08In esta memento bamos a pricarle el acir de barre,
  37. 3:12y esta bavolver ela gua un poco tó ma sclara,
  38. 3:22un qui dado y sintanta quercia.
  39. 3:28Y ból vemos a ser emizno proce de emiento,
  40. 3:31para me sclara, sincer tambruz coz conelviar.
  41. 3:36Y lista para plicar como poder ember que dado aliciramente,
  42. 3:43de oto color, de gamos pero esto mi entras nosiado,
  43. 3:51el lista para plicar.
  44. 3:55Nothien en ingu un a cosa estranga de entro,
  45. 3:59todos a de solvio perfaitamente, y aurita que siente un poco más,
  46. 4:05bá agarando un color, ma sclara.
  47. 4:10Y es un poco, la toso por qui tien es que tambruz cozado,
  48. 4:16a muchas personas que se les asejil marias veces en el intento,
  49. 4:21pero a forto nota mente eso no me pasami,
  50. 4:25pero este es un dato que tien es que tambruent.
  51. 4:30Si que y aseves como de ratar to a o el.

AOD-9604 DIY reconstitution: what the science says about this peptide

GriselskinLab❤️

TikTok creator

10.0K viewsWatch on TikTok

Quick answer

AOD-9604 (hGH fragment 176-191) is a synthetic peptide that failed to demonstrate significant weight loss efficacy in human clinical trials, despite earlier animal data suggesting fat metabolism activity. The video demonstrates home reconstitution using an acidic aqueous solution and a 50-unit insulin syringe, a process that carries sterility and contamination risks outside a pharmacy-grade environment. No licensed clinical indication exists for AOD-9604 in the United States, and its use falls outside standard telehealth prescribing frameworks.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For AOD-9604 DIY reconstitution: what the science says about this peptide, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

AOD-9604 DIY reconstitution: what the science says about this peptide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "AOD-9604 DIY reconstitution: what the science says about this peptide" from GriselskinLab❤️. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: AOD-9604 (hGH fragment 176-191) is a synthetic peptide that failed to demonstrate significant weight loss efficacy in human clinical trials, despite earlier animal data suggesting fat metabolism activity.

The reason this review is not generic is the source wording and the canonical claim label "peptides como idratar o mesclar aod 9604 te lo muestro paso a paso di." In this clip, the useful excerpt is: "I'll do that in a minute, anyway." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism in obese and beta3-AR knockout mice (2001), Increase of fat oxidation and weight loss in obese mice by a modified C-terminal GH fragment (2001), and Gateways to clinical trials (2005), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Acidic reconstitution solutions are chemically appropriate for hydrophobic peptides, but this is a lab technique, not a validated home procedure.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

AOD-9604 (hGH fragment 176-191) is a synthetic peptide that failed to demonstrate significant weight loss efficacy in human clinical trials, despite earlier animal data suggesting fat metabolism activity.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • AOD-9604 (hGH fragment 176-191) is a synthetic peptide that failed to demonstrate significant weight loss efficacy in human clinical trials, despite earlier animal data suggesting fat metabolism activity. The video demonstrates home reconstitution using an acidic aqueous solution and a 50-unit insulin syringe, a process that carries sterility and contamination risks outside a pharmacy-grade environment. No licensed clinical indication exists for AOD-9604 in the United States, and its use falls outside standard telehealth prescribing frameworks.
  • AOD-9604 failed its Phase IIb human clinical trial for weight loss and has no FDA-approved indication for any condition.
  • Acidic reconstitution solutions are chemically appropriate for hydrophobic peptides, but this is a lab technique, not a validated home procedure.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • AOD-9604 failed its Phase IIb human clinical trial for weight loss and has no FDA-approved indication for any condition.
  • Acidic reconstitution solutions are chemically appropriate for hydrophobic peptides, but this is a lab technique, not a validated home procedure.
  • Turbidity after reconstitution is not automatically safe to ignore; it can signal contamination or aggregation, not just incomplete mixing.
  • A 2022 CDC report linked hospitalizations to infections from injectable compounds prepared outside licensed sterile pharmacy facilities.
  • Unregulated peptide suppliers frequently deliver product with incorrect concentrations or bacterial endotoxins, with no way for a consumer to verify quality at home.
  • In the U.S., any injectable peptide therapy should come from a licensed 503A or 503B compounding pharmacy under a valid prescription, not from raw powder reconstituted at home.
  • The creator's own admission that many people fail multiple times at this process is evidence of the quality control problem inherent in DIY injectable preparation.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @griselenciso actually say?

The creator walked viewers through reconstituting AOD-9604 powder at home, step by step. The core instructions involved mixing the peptide with "agua acida" (acidic water or bacteriostatic water with acetic acid), adding it "very slowly" to avoid clumping, and using a 50-unit syringe. She also flagged that mixing too fast can cause the solution to turn cloudy and even "inflate" or clump, noting that "many people" fail multiple times before getting it right. She mentioned that the vial and water should both be at room temperature before mixing.

The transcript is heavily garbled, likely from auto-transcription of Spanish audio, so some nuance is lost. But the procedural outline is clear enough to evaluate: she's teaching a lay audience how to self-prepare an unregulated peptide compound at home without any clinical supervision.

Does the science back this up?

On the chemistry side, partially. AOD-9604 is a synthetic peptide fragment (hGH 176-191) that is poorly soluble in plain water, and acidic reconstitution solutions are genuinely used in research settings. The advice to add water slowly and keep everything at room temperature reflects real peptide handling practice. But the science supporting AOD-9604 itself is thin.

The peptide showed early promise in rodent studies for fat metabolism, but human trial results were disappointing. Heffernan et al. (2001, Journal of Endocrinology) showed AOD-9604 reduced body fat in obese mice without affecting IGF-1 levels. However, a Phase IIb human trial by Metabolic Pharmaceuticals found no statistically significant weight loss benefit over placebo, which contributed to the compound losing its FDA GRAS status reclassification bid in 2014. There is no peer-reviewed human trial demonstrating efficacy for fat loss at doses or concentrations typically used in DIY peptide communities.

What did they get wrong (or right)?

She got the reconstitution chemistry directionally right. Using dilute acetic acid solution to reconstitute hydrophobic peptides is standard in laboratory protocols, and the slow-addition technique does reduce aggregation risk. Credit where it's due.

But several things are either wrong or dangerously absent. First, there is no mention of sterile technique beyond the chemistry. Home reconstitution of injectable compounds without a laminar flow hood, sterile gloves, and aseptic procedure carries real infection risk, including abscess and sepsis. Second, she describes the solution as ready to inject even when "a little cloudy," which is not a safe standard. Turbidity in a reconstituted peptide can indicate aggregation or contamination, not just incomplete dissolution. Third, the peptide source is never discussed. Research-grade peptide purity varies enormously across vendors, and unverified suppliers frequently deliver product with bacterial endotoxins or incorrect concentrations (Melnikova et al., 2018, Journal of Pharmaceutical and Biomedical Analysis).

What should you actually know?

AOD-9604 is not FDA-approved for any indication. It is not a compounded drug available through licensed telehealth channels in the United States. Purchasing it from unregulated online vendors and reconstituting it at home puts you in contact with a compound of unknown purity, potency, and sterility.

The DIY peptide community treats reconstitution tutorials as empowering, but the risk profile here is not trivial. Injectable compounds prepared outside pharmacy-grade sterile conditions have caused hospitalizations. A 2022 CDC report documented infections linked to compounded injectable products prepared outside proper sterile facilities. Beyond safety, the efficacy case for AOD-9604 in humans remains unproven. If a clinician is recommending this compound, they should be sourcing it from a licensed 503A or 503B compounding pharmacy, not directing patients to reconstitute raw powder at home.

Bottom line

This video is a competent chemistry walkthrough wrapped around a legally and medically problematic activity. The reconstitution technique described has a basis in peptide science, but the context, self-injection of an unregulated compound prepared at home, makes the overall advice risky. The creator's acknowledgment that "many people fail several times" in the process should itself be a red flag: failed reconstitution attempts mean potential waste of an unknown compound or, worse, injecting a degraded or contaminated solution.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

GriselskinLab❤️ · TikTok creator

10.0K views on this video

COMO IDRATAR O MESCLAR AOD-9604, TE LO MUESTRO PASO A PASO. #diyproject#AOD#procesoDeCalidad#siluetforyou#cambioreal

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about aod-9604 failed its phase iib human clinical trial for weight?

AOD-9604 failed its Phase IIb human clinical trial for weight loss and has no FDA-approved indication for any condition.

What does the video say about acidic reconstitution solutions?

Acidic reconstitution solutions are chemically appropriate for hydrophobic peptides, but this is a lab technique, not a validated home procedure.

What does the video say about turbidity after reconstitution?

Turbidity after reconstitution is not automatically safe to ignore; it can signal contamination or aggregation, not just incomplete mixing.

What does the video say about a 2022 cdc report linked hospitalizations to infections from injectable?

A 2022 CDC report linked hospitalizations to infections from injectable compounds prepared outside licensed sterile pharmacy facilities.

What does the video say about unregulated peptide suppliers frequently deliver product with incorrect concentrations?

Unregulated peptide suppliers frequently deliver product with incorrect concentrations or bacterial endotoxins, with no way for a consumer to verify quality at home.

What does the video say about in the u.s., any injectable peptide therapy should come from?

In the U.S., any injectable peptide therapy should come from a licensed 503A or 503B compounding pharmacy under a valid prescription, not from raw powder reconstituted at home.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by GriselskinLab❤️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.